Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11
Highlights • CXCR3 ligands, CXCL9, CXCL10, and CXCL11, can act as a genetic vaccine adjuvant. • CXCL11 is the strongest vaccine adjuvant among the three CXCR3 ligands. • CXCL11 enhances antigen-specific CD8 T cells responses and memory generation. • CXCL11 enhances vaccine-induced anti-tumor activit...
Gespeichert in:
Veröffentlicht in: | Vaccine 2014-02, Vol.32 (10), p.1205-1212 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • CXCR3 ligands, CXCL9, CXCL10, and CXCL11, can act as a genetic vaccine adjuvant. • CXCL11 is the strongest vaccine adjuvant among the three CXCR3 ligands. • CXCL11 enhances antigen-specific CD8 T cells responses and memory generation. • CXCL11 enhances vaccine-induced anti-tumor activities. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2013.07.066 |